EXACT SCIENCES CORP (EXAS)
Data as of , from SEC Form 4 filings.
See up to 3 months of EXAS. The 7-day demo opens the 1M and 3M ranges and puts EXAS on your watchlist.
Start 7-day demoLatest EXAS insider trades
About EXACT SCIENCES CORP (EXAS)
EXACT SCIENCES CORP files with the SEC under CIK 0001124140 and is classified as medical laboratories. We track it alongside the rest of the Health Care sector.
EXAS Form 4 activity by transaction type, last 90 days
No Form 4 activity for EXAS in the last 90 days.
EXAS insider transactions (Form 4)
3352 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 1,500 footnote F1 | $70.08 | $105K | ||
| ||||||
| Brian Baranick - Officer | Open-market sale | Common Stock | 2,858 footnote F1 | $70.08 | $200K | |
| ||||||
| Katherine S. Zanotti | Open-market sale | Common Stock | 12,000 footnote F1 | $65.00 | $780K | |
| ||||||
| Open-market sale | Common Stock | 1,500 footnote F1 | $60.00 | $90K | ||
| ||||||
| James Edward Doyle | Open-market sale | Common Stock | 2,000 footnote F1 | $60.00 | $120K | |
| ||||||
| James Edward Doyle | Open-market sale | Common Stock | 1,485 | $42.02 | $62K | |
| Option exercise | Common Stock | 5,350 | $0.00 | - | ||
| Tax withholding / forfeiture | Common Stock | 2,515 | $46.83 | $118K | ||
| Option exercise | Restricted Stock Units | 5,350 | $0.00 | - | ||
| Brian Baranick - Officer | Option exercise | Common Stock | 5,350 | $0.00 | - | |
| Brian Baranick - Officer | Tax withholding / forfeiture | Common Stock | 2,717 | $46.83 | $127K | |
| Brian Baranick - Officer | Option exercise | Restricted Stock Units | 5,350 | $0.00 | - | |
| James Edward Doyle | Grant or award | Common Stock | 5,398 | $0.00 | - | |
| Michael J. Barber | Grant or award | Common Stock | 7,197 | $0.00 | - | |
| Paul J. Clancy | Grant or award | Common Stock | 5,398 | $0.00 | - | |
| Kimberly J. Popovits | Grant or award | Common Stock | 9,994 | $0.00 | - | |
| Grant or award | Common Stock | 7,670 | $0.00 | - | ||
| Shacey Petrovic | Grant or award | Common Stock | 5,398 | $0.00 | - | |
| Katherine S. Zanotti | Grant or award | Common Stock | 5,398 | $0.00 | - | |
| Katherine S. Zanotti | Open-market sale | Common Stock | 3,207 | $53.20 | $171K | |
| Daniel J. Levangie | Grant or award | Common Stock | 5,398 | $0.00 | - | |
| D. Scott Coward | Grant or award | Common Stock | 5,398 | $0.00 | - | |
| Grant or award | Common Stock | 363 | $38.26 | $14K | ||
| Grant or award | Restricted Stock Units | 7,334 | $0.00 | - | ||
| Grant or award | Common Stock | 8,527 | $0.00 | - | ||
| Aaron Bloomer - Officer | Option exercise | Common Stock | 11,556 | $0.00 | - | |
| Aaron Bloomer - Officer | Tax withholding / forfeiture | Common Stock | 5,120 | $44.25 | $227K | |
| Aaron Bloomer - Officer | Option exercise | Common Stock | 12,904 | $0.00 | - | |
| Aaron Bloomer - Officer | Tax withholding / forfeiture | Common Stock | 5,717 | $44.25 | $253K | |
| Aaron Bloomer - Officer | Option exercise | Restricted Stock Units | 11,566 | $0.00 | - | |
| Aaron Bloomer - Officer | Option exercise | Restricted Stock Units | 12,904 | $0.00 | - | |
| Kevin T. Conroy - Officer | Open-market purchase | Common Stock | 19,500 | $51.35 | $1.00M | |
| Brian Baranick - Officer | Open-market sale | Common Stock | 929 | $70.00 | $65K | |
Stock trades in EXAS disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Sale |
EXAS insider trading FAQ
What is the latest insider trade for EXAS?
EXACT SCIENCES CORP (EXAS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-23. The full record for EXAS runs to 52 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying EXAS stock?
No insider purchases of EXAS were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling EXAS stock?
No insider sales of EXAS were filed in the last 90 days. 10 sales are on record for this company.
Where can I see EXAS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects EXAS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brian Baranick view on EDGAR
- - James Herriott view on EDGAR
- - Aaron Bloomer view on EDGAR
- - Sarah Condella view on EDGAR
- - Kevin T. Conroy view on EDGAR
- - Jacob A. Orville view on EDGAR
- - D. Scott Coward view on EDGAR
- - Shacey Petrovic view on EDGAR
- - Katherine S. Zanotti view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where EXAS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow EXAS with a 7-day demo
- EXAS on your watchlist
- Every EXAS Form 4 filing on record
- Up to 3 months of EXAS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive